X155 – Subsequent test - high risk patient or therapy monitoring or risk factor for secondary osteoporosis - two or more sites

Subsequent test for a high-risk patient, involving two or more sites. BMD measurement by DXA is an insured service only when rendered for the prevention and management of osteoporosis or osteopenia. When more than one site is measured, the sites must include both hip and spine, unless measurement of both is not technically feasible (e.g., due to prosthesis or deformity), in which case either hip or spine is measured. A 'high risk patient' is defined as a patient: 1. at risk for accelerated bone loss (in the absence of other risk factors, patient age is deemed not to place a patient at high risk for accelerated bone loss); 2. with osteopenia or osteoporosis on any previous BMD testing; or 3. with bone loss in excess of 1% per year as demonstrated by previous BMD testing.